Composite medicament stent for inhibiting cardiovascular restenosis and preparation method

A restenosis and cardiovascular technology, which is applied in the field of composite drug stents and preparations for inhibiting cardiovascular restenosis, can solve the problems of ineffective endothelial effect of vascular endothelial progenitor cells, and achieve the goal of preventing thrombus, restenosis, and good activity Effect
CN101869723AInactive Publication Date: 2010-10-27่ตต่
0 Cites 18 Cited by

Patent Information

Authority / Receiving Office
CN ยท China
Current Assignee / Owner
่ตต่
Publication Date
2010-10-27
Estimated Expiration
Not applicable ยท inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to a composite medicament stent for inhibiting cardiovascular restenosis and a preparation method. The stent is prepared by performing laser cutting on a metal tube; the surface of the stent is corroded by electrochemical acid solution so as to form nanopores; the surface of a main body is coated with a nondegradable bioactive coating with thickness of 10 to 50 microns; a degradable biocompatible polymer medicament coating with thickness of 10 to 100 microns are coated outside the nondegradable bioactive coating; the nondegradable bioactive coating is prepared by mixing a nondegradable biocompatible high polymer, active biological components, an organic solvent and the like to form solution and spraying and drying the solution and the like; and the medicament coating is prepared by mixing a degradable biocompatible high polymer, anti-restenosis medicament ingredients, an organic solvent and the like to form solution and spraying and drying the solution and the like. The composite medicament stent has the characteristics of slow medicament release and capability of effectively reducing restenosis and thrombosis at the later stage of stent implantation.
Need to check novelty before this filing date? Find Prior Art

Description

(1) Technical field

[0001] The invention belongs to the field of medical equipment, and relates to a composite drug stent for inhibiting cardiovascular restenosis for minimally invasive interventional treatment of cardiovascular diseases and a preparation method thereof. (2) Background technology

[0002] Coronary atherosclerotic heart disease is one of the important causes of death from cardiovascular diseases, and it is a common disease that seriously threatens human life and health. With the improvement of human living standards and the aging process of the population, the incidence of this disease is on the rise. In 1987, Sigwart and others used intravascular metal stents for the first time to treat coronary artery stenosis, and received ideal results. Since then, they have created a new way to treat various vascular blockages and stenosis diseases. At present, percutaneous coronary angioplasty (PTCA) has become a common method for clinical treatment of coronary heart d...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More